● Recruiting

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Condition: Chronic Myeloid Leukemia · Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Cml · Sponsor: Enliven Therapeutics

PhasePhase 1

Planned participants250

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in patients with chronic myeloid leukemia with and without T315I mutations in patients who are relapsed, refractory or intolerant to TKIs.

This description comes directly from the study's public registry record.

Talk to the study team

Study Contact · 707-799-3272 · ELVN-001-101@enliventherapeutics.com

Always discuss trial participation with your own doctor first.

Locations (45)

Memorial Sloan Kettering Cancer Center	New York, New York, United States	Recruiting
Montefiore Medical Center	The Bronx, New York, United States	Recruiting
Oregon Health & Science University-Knight Cardiovascular Institute	Portland, Oregon, United States	Recruiting
The University of Texas MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
Royal Adelaide Hospital	Adelaide, Australia	Recruiting
UZ Gent	Ghent, Belgium	Recruiting
UZ Leuven	Leuven, Belgium	Recruiting
CHU Liege	Liège, Belgium	Recruiting
University Health Network (UHN) - Princess Margaret Cancer Centre	Toronto, Ontario, Canada	Recruiting
CHU Amiens Picardie Site Sud	Amiens, France	Recruiting
Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest	Bordeaux, France	Recruiting
CHRU de Lille - Hopital Calmette-Boulevard du Pr Leclercq CHRU Lille	Lille, France	Recruiting

+ 33 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05304377